Physiologic Insights from the COPD Genetic Epidemiology Study.
COPD Genetic Epidemiology
COPDGene
PRISm
Preserved Ratio Impaired Spirometry
asthma-COPD overlap
chronic obstructive pulmonary disease
copd
Journal
Chronic obstructive pulmonary diseases (Miami, Fla.)
ISSN: 2372-952X
Titre abrégé: Chronic Obstr Pulm Dis
Pays: United States
ID NLM: 101635411
Informations de publication
Date de publication:
24 07 2019
24 07 2019
Historique:
entrez:
26
7
2019
pubmed:
26
7
2019
medline:
26
7
2019
Statut:
ppublish
Résumé
COPD Genetic Epidemiology Study (COPDGene
Identifiants
pubmed: 31342731
doi: 10.15326/jcopdf.6.3.2019.0128
pmc: PMC6872216
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
256-266Subventions
Organisme : NHLBI NIH HHS
ID : U01 HL089856
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL089897
Pays : United States
Organisme : COPD Foundation Industry Advisory Board
Pays : International
Informations de copyright
JCOPDF © 2019.
Déclaration de conflit d'intérêts
WWS reports research grants from Boehringer Ingelheim, AstraZeneca, Astellas and consulting with Allergan and Syneos Health. SPB has received research grants from the National Institutes of Health (K23HL133438) and from ProterixBio. He has served on advisory boards for Sunovion and GlaxoSmithKline. MCM reports royalties for authorship from UpToDate and consulting with GlaxoSmithKline. BJM reports consulting agreements and/or grant funding and/or advisory board service for AstraZeneca, the National Heart Lung and Blood Institute, Spiration, GlaxoSmithKline, Sunovion, Pearl, Verona, Boehringer Ingelheim, Theravance, Circassia, Third Pole, Shire, and Phillips. RC reports research grants from Boehringer Ingelheim, Astra Zeneca, Astellas, Glaxo SmithKline; service on advisory boards from Boehringer Ingelheim, GlaxoSmithKline; consulting for Regeneron, Genetech; speakers bureau for Boehringer Ingelheim, Astra Zeneca and GlaxoSmithKline. JP has nothing to declare.
Références
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
pubmed: 11316667
Ann Am Thorac Soc. 2016 Sep;13(9):1483-9
pubmed: 27268723
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1397-1405
pubmed: 29874098
Thorax. 2012 May;67(5):399-406
pubmed: 22514236
Chest. 2009 May;135(5):1345-1352
pubmed: 19420202
Ann Am Thorac Soc. 2014 Mar;11(3):335-41
pubmed: 24450777
Am J Respir Crit Care Med. 2011 Jul 1;184(1):57-63
pubmed: 21493737
Chest. 2016 Nov;150(5):1080-1090
pubmed: 27452770
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Chronic Obstr Pulm Dis. 2015 Mar 10;2(2):94-102
pubmed: 28848835
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1358-1360
pubmed: 30016598
Thorax. 2014 May;69(5):409-14
pubmed: 23525095
Am J Respir Crit Care Med. 2012 Apr 1;185(7):756-62
pubmed: 22268134
Respir Res. 2014 Aug 06;15:89
pubmed: 25096860
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Chest. 2011 Apr;139(4):878-886
pubmed: 20724741
Pulm Pharmacol Ther. 2003;16(2):67-78
pubmed: 12670776
BMC Pulm Med. 2014 Sep 19;14:148
pubmed: 25233902
Thorax. 2010 Jun;65(6):499-504
pubmed: 20522846
N Engl J Med. 2004 Mar 4;350(10):1005-12
pubmed: 14999112
Chest. 2012 Apr;141(4):867-875
pubmed: 21960696
Int J Tuberc Lung Dis. 2012 Oct;16(10):1405-11
pubmed: 22863565
Nat Med. 2012 Nov;18(11):1711-5
pubmed: 23042237
Respir Res. 2016 Nov 10;17(1):147
pubmed: 27832774
JAMA Intern Med. 2015 Sep;175(9):1539-49
pubmed: 26098755
COPD. 2010 Feb;7(1):32-43
pubmed: 20214461
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1483-1493
pubmed: 27332504
Am J Respir Crit Care Med. 2016 Apr 1;193(7):727-35
pubmed: 26540012
Am J Respir Crit Care Med. 2017 Sep 1;196(5):569-576
pubmed: 28481639
Chest. 2007 Feb;131(2):349-55
pubmed: 17296632
BMJ Open Respir Res. 2017 Dec 18;4(1):e000213
pubmed: 29435342
Am J Respir Crit Care Med. 2015 Oct 1;192(7):817-25
pubmed: 26114439
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330
pubmed: 27556408
Proc Am Thorac Soc. 2008 May 1;5(4):475-7
pubmed: 18453358